Cabio Biotech Wuhan Co Ltd (688089) — Cash Flow Quality Index
Cabio Biotech Wuhan Co Ltd (688089) has a Cash Flow Quality Index of 2.62x as of September 2025. Operating cash flow of CN¥56.10 Million exceeds net income of CN¥21.39 Million, indicating high earnings quality where cash backs reported profits. Explore 688089 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cabio Biotech Wuhan Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Cabio Biotech Wuhan Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Cabio Biotech Wuhan Co Ltd generate cash.
Annual Cash Flow Quality Index for Cabio Biotech Wuhan Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Cabio Biotech Wuhan Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.44x | CN¥173.04 Million | CN¥120.13 Million | ▲ +91.1% |
| 2023 | 0.75x | CN¥68.89 Million | CN¥91.37 Million | ▼ -73.7% |
| 2022 | 2.86x | CN¥176.40 Million | CN¥61.59 Million | ▲ +264.1% |
| 2021 | 0.79x | CN¥103.29 Million | CN¥131.29 Million | ▼ -27.2% |
| 2020 | 1.08x | CN¥145.88 Million | CN¥134.94 Million | ▼ -1.9% |
| 2019 | 1.10x | CN¥131.95 Million | CN¥119.75 Million | ▲ +1.5% |
| 2018 | 1.09x | CN¥106.16 Million | CN¥97.83 Million | ▼ -29.3% |
| 2017 | 1.53x | CN¥100.66 Million | CN¥65.59 Million | ▲ +13.8% |
| 2016 | 1.35x | CN¥62.53 Million | CN¥46.35 Million | ▼ -40.9% |
| 2015 | 2.28x | CN¥44.58 Million | CN¥19.55 Million | ▲ +85.4% |
| 2014 | 1.23x | CN¥46.34 Million | CN¥37.66 Million | ▲ +45.6% |
| 2013 | 0.85x | CN¥39.48 Million | CN¥46.70 Million | — |